Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination
Clinical trial NCT00889889 · COMPLETED
Trial details
- NCT number
- NCT00889889
- Sponsor
- Abbott Biologicals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-01-01
- Enrollment
- 1270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.